[HTML][HTML] New strategies for overcoming limitations of mesenchymal stem cell-based immune modulation

N Kim, SG Cho - International journal of stem cells, 2015 - synapse.koreamed.org
Mesenchymal stem cells (MSCs) have rapidly been applied in a broad field of immune-
mediated disorders since the first successful clinical use of MSCs for treatment of graft …

Human mesenchymal stem cells (MSCs) for treatment towards immune-and inflammation-mediated diseases: review of current clinical trials

LT Wang, CH Ting, ML Yen, KJ Liu, HK Sytwu… - Journal of biomedical …, 2016 - Springer
Human mesenchymal stem cells (MSCs) are multilineage somatic progenitor/stem cells that
have been shown to possess immunomodulatory properties in recent years. Initially met with …

Mesenchymal stem cell‐based immunomodulation: properties and clinical application

M Wang, Q Yuan, L Xie - Stem cells international, 2018 - Wiley Online Library
Mesenchymal stem cells (MSCs) are multipotent stem cells characterized by self‐renewal,
production of clonal cell populations, and multilineage differentiation. They exist in nearly all …

Mesenchymal stem cell therapy for the treatment of inflammatory diseases: challenges, opportunities, and future perspectives

S Regmi, S Pathak, JO Kim, CS Yong… - European journal of cell …, 2019 - Elsevier
Mesenchymal stem cells (MSCs) are promising alternative agents for the treatment of
inflammatory disorders due to their immunomodulatory functions, and several clinical trials …

[HTML][HTML] Mesenchymal stem cell treatment for autoimmune diseases: a critical review

FE Figueroa, F Carrión, S Villanueva, M Khoury - Biological research, 2012 - SciELO Chile
Mesenchymal stem cells (MSCs) are now known to display not only stem cell multipotency,
but also robust antiinflammatory and regenerative properties. After widespread in-vitro and …

Mesenchymal stromal cell based therapies for the treatment of immune disorders: recent milestones and future challenges

A Gonzalez-Pujana, M Igartua… - Expert opinion on …, 2020 - Taylor & Francis
ABSTRACT Introduction: Mesenchymal stromal cells (MSCs) present unique
immunomodulatory properties that make them promising candidates for the treatment of …

Mesenchymal stem cell therapy for autoimmune disease: risks and rewards

H Munir, HM McGettrick - Stem cells and development, 2015 - liebertpub.com
Mesenchymal stem cells (MSC) possess a range of immunomodulatory properties which
they exert through soluble mediators and through direct cell–cell contact. Due to these …

[HTML][HTML] Mesenchymal stem cells: Immunomodulatory capability and clinical potential in immune diseases

Q Zhao, H Ren, Z Han - Journal of cellular immunotherapy, 2016 - Elsevier
Mesenchymal stem cells (MSCs) represent a heterogenous population of adult, fibroblast-
like multi-potent cells. MSCs have drawn much attention during the last decade in the field of …

Overcoming immunoregulatory plasticity of mesenchymal stem cells for accelerated clinical applications

N Kim, SG Cho - International journal of hematology, 2016 - Springer
Mesenchymal stem cells (MSCs) are multipotent stromal cells with the potential to
differentiate into different tissue lineages. In addition to their differentiation potential, MSCs …

Moving from the laboratory bench to patients' bedside: considerations for effective therapy with stem cells

LS Sherman, J Munoz, SA Patel… - Clinical and …, 2011 - Wiley Online Library
Although stem cell therapy is not a new field, the field was limited to transplantation of
hematopoietic stem cells. Such transplantation has provided invaluable information for the …